One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment

被引：0
|
作者：
Lei Shi
You Zheng
Zhi Cheng
Ningfei Ji
Changming Niu
Yan Wang
Tingrong Huang
Ruyou Li
Mao Huang
Xiaolin Chen
Lei Shu
Mingjing Wu
Kaili Deng
Jing Wei
Xueli Wang
Yang Cao
Jiaxin Yan
Ganzhu Feng
机构：
[1] the Second Affiliated Hospital of Nanjing Medical University,Department of Pulmonary and Critical Medicine
[2] Huangshi Hospital of Traditional Chinese Medicine,Department of Nephrology
[3] the Second Affiliated Hospital of Nanjing Medical University,Department of Critical Care Medicine
[4] The First Affiliated Hospital of Nanjing Medical University,Department of Respiratory and Critical Care Medicine
[5] Jiangsu Cell Tech Medical Research Institute,Department of Respiratory Medicine
[6] Huangshi Central Hospital,Department of Pulmonary and Critical Care Medicine
[7] the Second Affiliated Hospital of Nanjing Medical University,Department of Respiratory Medicine, Sir Run Run Hospital
[8] Nanjing Medical University,undefined
来源：
Stem Cell Research & Therapy | / 13卷
关键词：
Coronavirus disease 2019 (COVID-19); Human umbilical cord mesenchymal stem cells (h-UC-MSCs); 1-Year follow-up; Sequelae; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 27 条
  • [1] One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment
    Shi, Lei
    Zheng, You
    Cheng, Zhi
    Ji, Ningfei
    Niu, Changming
    Wang, Yan
    Huang, Tingrong
    Li, Ruyou
    Huang, Mao
    Chen, Xiaolin
    Shu, Lei
    Wu, Mingjing
    Deng, Kaili
    Wei, Jing
    Wang, Xueli
    Cao, Yang
    Yan, Jiaxin
    Feng, Ganzhu
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [2] Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study
    Feng, Ying
    Huang, Jianying
    Wu, Jianyuan
    Xu, Yan
    Chen, Bo
    Jiang, Lijun
    Xiang, Hui
    Peng, Zhiyong
    Wang, Xinghuan
    CELL PROLIFERATION, 2020, 53 (12)
  • [3] COVID-19 vaccines: safety profile after one year of follow-up
    Fernandez-Varela, Alba Maria
    Granero-Lopez, Monica
    Rodriguez-Rodriguez, Alejandro
    Rodriguez-Penin, Isaura
    ARS PHARMACEUTICA, 2024, 65 (01) : 6 - 12
  • [4] One-year follow-up CT findings in COVID-19 patients: A systematic review and meta-analysis
    Watanabe, Atsuyuki
    So, Matsuo
    Iwagami, Masao
    Fukunaga, Koichi
    Takagi, Hisato
    Kabata, Hiroki
    Kuno, Toshiki
    RESPIROLOGY, 2022, 27 (08) : 605 - 616
  • [5] Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study
    Dandan Wang
    Lingying Niu
    Xuebing Feng
    Xinran Yuan
    Shengnan Zhao
    Huayong Zhang
    Jun Liang
    Cheng Zhao
    Hong Wang
    Bingzhu Hua
    Lingyun Sun
    Clinical and Experimental Medicine, 2017, 17 : 333 - 340
  • [6] Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study
    Wang, Dandan
    Niu, Lingying
    Feng, Xuebing
    Yuan, Xinran
    Zhao, Shengnan
    Zhang, Huayong
    Liang, Jun
    Zhao, Cheng
    Wang, Hong
    Hua, Bingzhu
    Sun, Lingyun
    CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 17 (03) : 333 - 340
  • [7] One Year Follow-Up of COVID-19 Related Symptoms and Patient Quality of Life: A Prospective Cohort Study
    Kim, Yoonjung
    Kim, Shin-Woo
    Chang, Hyun-Ha
    Kwon, Ki Tae
    Hwang, Soyoon
    Bae, Sohyun
    YONSEI MEDICAL JOURNAL, 2022, 63 (06) : 499 - 510
  • [8] Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up
    Wang, Xiaohua
    Yin, Xiaoguang
    Sun, Wei
    Bai, Jin
    Shen, Yawen
    Ao, Qiang
    Gu, Yongquan
    Liu, Ying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (05) : 2255 - 2258
  • [9] Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials
    Qinxue Liu
    Fengjie Ma
    Yizhi Zhong
    Gaojian Wang
    Li Hu
    Yaping Zhang
    Junran Xie
    Stem Cell Research & Therapy, 14
  • [10] Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials
    Liu, Qinxue
    Ma, Fengjie
    Zhong, Yizhi
    Wang, Gaojian
    Hu, Li
    Zhang, Yaping
    Xie, Junran
    STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
123